Valuation: DRI Healthcare Trust

Capitalization 64Cr 55Cr 51Cr 48Cr 89Cr 6.23TCr 91Cr 605.58Cr 235.83Cr 2.93TCr 241.35Cr 236.21Cr 10TCr P/E ratio 2026 *
30x
P/E ratio 2027 * 15.1x
Enterprise value 106.27Cr 92Cr 84Cr 79Cr 146.27Cr 10TCr 149.95Cr 1TCr 389.67Cr 4.84TCr 398.79Cr 390.29Cr 17TCr EV / Sales 2026 *
5.44x
EV / Sales 2027 * 5.04x
Free-Float
99.83%
Yield 2026 *
3.72%
Yield 2027 * 3.81%
1 day-0.31%
1 week+1.32%
Current month-0.98%
1 month-4.91%
3 months-0.62%
6 months-0.74%
Current year+0.12%
1 week 15.65
Extreme 15.65
16.55
1 month 15.65
Extreme 15.65
17
Current year 15
Extreme 15
17.69
1 year 12.51
Extreme 12.51
17.69
3 years 9.33
Extreme 9.33
17.69
5 years 5.83
Extreme 5.83
17.69
10 years 5.83
Extreme 5.83
17.69
Manager TitleAgeSince
Chief Executive Officer 63 08/07/2024
Director of Finance/CFO - 01/10/2025
Chief Tech/Sci/R&D Officer - 01/09/2014
Director TitleAgeSince
Director/Board Member 66 22/01/2021
Director/Board Member 59 09/06/2025
Chairman 63 22/01/2021
Change 5d. change 1-year change 3-years change Capi.($)
-0.31%+1.32%+27.60%+65.88% 65Cr
+3.37%+3.19%+35.27%+130.89% 88TCr
+0.47%+2.56%+50.83%+44.74% 55TCr
+2.08%+2.84%+15.10%+47.31% 37TCr
+0.88%+0.40%+24.15%+11.99% 33TCr
+1.57%+2.71%+30.03%+31.52% 28TCr
+1.24%+0.96%+33.82%+15.57% 28TCr
+1.49%+1.66%+47.92%-1.08% 28TCr
+0.52%-3.04%-34.47%-50.00% 20TCr
+1.96%-1.65%+19.90%+48.04% 18TCr
Average +1.33%+1.19%+25.02%+34.48% 33.49TCr
Weighted average by Cap. +1.78%+2.06%+30.08%+51.68%

Financials

2026 *2027 *
Net sales 20Cr 17Cr 15Cr 15Cr 27Cr 1.89TCr 28Cr 183.81Cr 72Cr 889.75Cr 73Cr 72Cr 3.11TCr 20Cr 18Cr 16Cr 15Cr 28Cr 1.97TCr 29Cr 191.41Cr 75Cr 926.53Cr 76Cr 75Cr 3.24TCr
Net income 1.81Cr 1.56Cr 1.43Cr 1.35Cr 2.48Cr 174.8Cr 2.55Cr 17Cr 6.62Cr 82Cr 6.78Cr 6.63Cr 287.34Cr 3.4Cr 2.93Cr 2.68Cr 2.53Cr 4.67Cr 328.7Cr 4.79Cr 32Cr 12Cr 154.74Cr 13Cr 12Cr 540.33Cr
Net Debt 42Cr 36Cr 33Cr 31Cr 58Cr 4.06TCr 59Cr 395.03Cr 153.84Cr 1.91TCr 157.44Cr 154.08Cr 6.68TCr 38Cr 33Cr 30Cr 28Cr 52Cr 3.69TCr 54Cr 358.83Cr 139.74Cr 1.74TCr 143.01Cr 139.96Cr 6.07TCr
Logo DRI Healthcare Trust
DRI Healthcare Trust is a global pharmaceutical royalty monetization company. The Company's portfolio consists of 29 royalty streams on 23 products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. Its Royalty Assets include Ekterly, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Spinraza, Vonjo I, Vonjo II, Xolair, Zejula, Zytiga, and others. The Ekterly is an oral on-demand therapy for treating attacks associated with Hereditary Angioedema (HAE). The Eylea I is a vascular endothelial growth factor inhibitor initially indicated for the treatment of neovascular wet age-related macular degeneration. Natpara is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.
Employees
32
Date Price Change Volume
19/26/19 16.09 $ -0.31% 1,52,266
15/26/15 16.14 $ +2.48% 86,178
14/26/14 15.75 $ -1.01% 60,049
13/26/13 15.91 $ +0.19% 61,015
12/26/12 15.88 $ -0.13% 34,538
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
11.69USD
Average target price
16.18USD
Spread / Average Target
+38.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DHT.UN Stock